BK polyomavirus is a small, non‑enveloped DNA virus that infects humans early in life and establishes latent infection in the kidneys, reactivating to cause disease when host immunity is compromised.
Explanation
BK polyomavirus (BKPyV) belongs to the family Polyomaviridae and has a circular double‑stranded DNA genome of about 5 kilobases packaged within an icosahedral capsid composed primarily of the VP1 protein. Primary infection usually occurs in childhood through respiratory or oral routes and is generally asymptomatic; the virus then persists in renal tubular epithelial cells and urothelium. The genome contains an early region encoding large and small T antigens that drive viral replication and modulate cell cycle pathways, and a late region encoding capsid proteins VP1, VP2 and VP3. In immunocompetent hosts, viral replication is controlled by cell‑mediated immunity and remains at low levels. In the context of immunosuppression, particularly after kidney and hematopoietic stem‑cell transplantation, BKPyV can reactivate and replicate vigorously. High levels of viruria and viremia lead to direct cytopathic effects and inflammation in the kidney and bladder. Diagnosis relies on detection of viral DNA by PCR, quantification of viral loads in plasma or urine, and identification of decoy cells with viral inclusions. No specific antiviral agents are approved; management involves reduction of immunosuppression, with agents like cidofovir or leflunomide used experimentally.
Clinical significance and examples
BK virus‑associated nephropathy is a major cause of graft dysfunction and loss in renal transplant recipients; biopsy shows tubulointerstitial nephritis with intranuclear viral inclusions. Routine screening of transplant recipients for BKPyV DNA in plasma allows early detection and adjustment of immunosuppression to prevent nephropathy. Hemorrhagic cystitis due to BKPyV can occur after hematopoietic stem‑cell transplantation, leading to bladder pain and hematuria. In healthy individuals, viruria is common but usually clinically silent. Decoy cells containing BK viral inclusions may be shed in the urine and can be misinterpreted as malignant cells in cytology specimens. Research into BKPyV pathogenesis has enhanced understanding of polyomavirus biology and interactions with host cell cycle control.
Monitoring and understanding BK polyomavirus is critical for the management of transplant patients. Its ability to remain latent and reactivate underscores the importance of immune surveillance in controlling polyomavirus infections.
Related Terms: Polyomavirus, JC Polyomavirus, Nephropathy, Immunosuppression, Decoy cells